| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |